 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

1. Introduction and context

1.1 What is a clinical evaluation?

1.3 Regulatory context: MDR and UK MDR

1.6 Link between clinical evaluation, PMS and PMCF

2. Key definitions and regulatory requirements

2.2 MDR Annex XIV Part A – what is actually required?

2.3 How Annex XIV links clinical evaluation to risk management and usability

3. Roles, responsibilities and documentation set

3.2 Clinical evaluators and reviewers: roles and qualifications

3.3 The core documentation set

4. Clinical Evaluation Plan (CEP)

4.1 Purpose of the CEP and when to create it

4.3 Relevant GSPRs that require clinical evidence

4.6 Methods and criteria for identification, appraisal and analysis of data

5. Stepwise clinical evaluation process (Stages 0–3)

5.1 Stage 0 – Define scope

5.2 Stage 1 – Identification of pertinent data

5.3 Stage 2 – Appraisal of data

5.4 Stage 3 – Analysis of clinical data

6. Clinical Evaluation Report (CER)

6.2 Typical CER structure

7. Equivalence and use of existing data

7.1 What “equivalence” means in practice

7.2 Limitations on using equivalence under MDR

7.3 Practical examples: strong vs weak equivalence

8. Integration with risk management, usability and PMS/PMCF

8.1 Clinical evaluation and risk management

8.3 Ongoing clinical evaluation, PMS and PMCF

9. Special topics for mini-courses

9.1 Software as a Medical Device (SaMD) – special clinical evaluation issues

10. Common pitfalls and best practices

10.1 Frequent CER deficiencies

10.2 Practical best practices

Quiz

Quiz 1: Fundamentals and Regulatory Context

Quiz 2: CEP and Data Identification

Quiz 3: Data Appraisal and Analysis

Quiz 4: Equivalence and Reporting

Quiz 5: Lifecycle Integration and Best Practices

Survey and Feedback

Course Evaluation Survey

Badge Card

Welcome to "Mastering Medical Device Clinical Evaluation for MDR and UK MDR," the definitive online course designed to help you navigate the complex regulatory landscapes of the European Union and the United Kingdom. With the transition to the EU Medical Device Regulation (MDR) and the evolving UK MDR, regulatory affairs professionals, clinical evaluators, and medical device manufacturers face unprecedented challenges in demonstrating device safety, performance, and a favorable benefit-risk profile.

$ (USD)

Welcome to "Mastering Medical Device Clinical Evaluation for MDR and UK MDR," the definitive online course designed to help you navigate the complex regulatory landscapes of the European Union and the United Kingdom. With the transition to the EU Medical Device Regulation (MDR) and the evolving UK MDR, regulatory affairs professionals, clinical evaluators, and medical device manufacturers face unprecedented challenges in demonstrating device safety, performance, and a favorable benefit-risk profile. This comprehensive course demystifies the stringent requirements of MDR Annex XIV Part A, providing you with a clear, actionable roadmap for conducting robust clinical evaluations.

Throughout this program, you will explore the entire clinical evaluation lifecycle, from drafting a strategic Clinical Evaluation Plan (CEP) to executing the stepwise evaluation process (Stages 0-3) and compiling a compliant Clinical Evaluation Report (CER). We delve deep into critical topics such as leveraging clinical equivalence, integrating clinical data with ISO 14971 risk management and IEC 62366 usability engineering, and establishing a continuous feedback loop with Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF).

Whether you are dealing with legacy devices, innovative new products, or Software as a Medical Device (SaMD), this course equips you with the practical tools, best practices, and methodological rigor required to avoid common Notified Body deficiencies. Join us to elevate your regulatory compliance strategy, ensure seamless market access, and master the art of medical device clinical evaluation.

Medical Devices: Clinical Evaluation

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The era of relying on historical assumptions and loosely defined equivalence claims has come to an abrupt end. Under the rigorous frameworks of the EU Medical Device Regulation (MDR) and the UK MDR, clinical evaluation has evolved from a static, retrospective exercise into a dynamic, lifecycle-long mandate. This shift raises a critical question for every regulatory and quality professional: is your clinical evidence truly robust enough to demonstrate a favorable benefit-risk profile under the scrutiny of modern General Safety and Performance Requirements (GSPRs), or is it merely a "tick-box" exercise vulnerable to Notified Body rejection? Understanding the fundamental objectives of clinical evaluation requires a departure from traditional technical testing, demanding instead a continuous synthesis of data that proves safety and performance in the real world.</p>

<p>Navigating the methodological requirements of Annex XIV Part A necessitates a sophisticated mastery of data appraisal, systematic literature searching, and the nuanced application of equivalence—which is now more restricted than ever before. This course challenges you to look beyond the surface of the Clinical Evaluation Report (CER) and examine the deep interdependencies between risk management (ISO 14971), usability (IEC 62366), and post-market clinical follow-up (PMCF). As we dissect the stepwise process from Stage 0 scoping to the complexities of Software as a Medical Device (SaMD), you must evaluate whether your organization possesses the multi-disciplinary competencies required to maintain compliance. By identifying frequent deficiencies and adopting industry-proven best practices, you will transform your technical documentation from a regulatory hurdle into a defensible, scientifically sound asset that ensures ongoing market access in an increasingly demanding global landscape.</p>
        </div>
    </div>
</div>
